Discover 977 paid clinical trials in San Antonio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Aulos Bioscience, Inc.
Location:
Code:
NCT05267626
Conditions
Advanced Solid Tumor
Metastatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
AU-007
Aldesleukin
Avelumab
Sponsor:
GB002, Inc.
Location:
Code:
NCT05934526
Conditions
Pulmonary Arterial Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Seralutinib
Generic Dry Powder Inhaler
Sponsor:
XenoPort, Inc.
Location:
Code:
NCT02560766
Conditions
RLS
Eligibility Criteria
Sex: All
Age: 13 - 17
Healthy Volunteers: Not accepted
Interventions
HORIZANT 300 mg
HORIZANT 600 mg
Placebo
Sponsor:
TORL Biotherapeutics, LLC
Location:
Code:
NCT05156866
Conditions
Advanced Solid Tumor
Gastric Cancer
Pancreas Cancer
Gastroesophageal Junction Adenocarcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TORL-2-307-ADC
Sponsor:
OncoResponse, Inc.
Location:
Code:
NCT06090266
Conditions
Cancer
Tumor, Solid
Malignant Neoplasm
Metastatic Cancer
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
OR502
Cemiplimab
Sponsor:
AstraZeneca
Location:
Code:
NCT06283966
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
BGF MDI 320/14.4/9.6 μg
GFF MDI 14.4/9.6 μg
Sponsor:
AstraZeneca
Location:
Code:
NCT06502366
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BDA MDI HFO 160/180 μg
BDA MDI HFA 160/180 μg
Placebo MDI HFA
Sponsor:
NRG Oncology
Location:
Code:
NCT05879926
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 60
Healthy Volunteers: Not accepted
Interventions
Ovarian Function Suppression + Aromatase Inhibitor
Adjuvant Chemotherapy + Ovarian Function Suppression
Sponsor:
CinPhloro Pharma, LLC
Location:
Code:
NCT06153420
Conditions
Irritable Bowel Syndrome With Diarrhea
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CIN-103
Placebo
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT04958265
Conditions
Atypical Hemolytic Uremic Syndrome
Eligibility Criteria
Sex: All
Age: 28 - 17
Healthy Volunteers: Not accepted
Interventions
Crovalimab
With a robust healthcare network and several renowned medical research institutions, San Antonio is a key hub for clinical research. Leading organizations such as UT Health San Antonio, Brooke Army Medical Center, and the Texas Biomedical Research Institute are at the forefront of groundbreaking studies.
These institutions are recognized for their expertise in areas like cancer, infectious diseases, trauma care, and military health, positioning San Antonio as an important city in advancing medical research and improving patient outcomes.
For those keen to participate in clinical trials, San Antonio offers distinct advantages. The city’s diverse population provides a wide range of participants, making research findings more reliable and applicable across various demographics.
By joining a clinical trial in San Antonio, participants not only gain access to cutting-edge treatments but also contribute to critical advancements in medical research. The city’s well-established research infrastructure and supportive medical community ensure high-quality care and valuable contributions.
San Antonio plays a crucial role in advancing medical research through clinical trials across a wide array of diseases and medical conditions.
Clinical trials in San Antonio have focused on diseases such as HIV/AIDS, tuberculosis, and hepatitis C, as well as emerging infections like Zika, Ebola, and COVID-19. The Texas Biomedical Research Institute, in particular, is globally recognized for its research on infectious diseases.
San Antonio researchers are pivotal in the development of new vaccines, antiviral drugs, and diagnostic tools that not only address local public health concerns but also have global implications.
With Brooke Army Medical Center and the Center for the Intrepid at Fort Sam Houston, San Antonio is a global leader in trauma and military medicine. Clinical trials often focus on improving treatments for combat-related injuries, including traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), and severe burns. Additionally, research on advanced prosthetics, rehabilitation techniques, and chronic pain management therapies is transforming recovery for wounded soldiers, with implications for civilian trauma care as well.
San Antonio has become a leader in oncology research, with Mays Cancer Center at UT Health San Antonio being a National Cancer Institute (NCI)-designated Cancer Center. Clinical trials here focus on a variety of cancers, including breast, prostate, lung, and colorectal cancers.
The city is at the forefront of innovative treatments like immunotherapy, which uses the body’s immune system to fight cancer, and targeted therapies, which attack specific cancer cells based on genetic markers. These trials offer patients early access to cutting-edge treatments while pushing the boundaries of cancer care.
Given the high prevalence of diabetes in the region, especially among the Hispanic population, San Antonio is a leader in diabetes research. Clinical trials at institutions like UT Health San Antonio and the Texas Diabetes Institute explore new insulin therapies, non-invasive blood sugar monitoring technologies, and lifestyle interventions aimed at better managing Type 1 and Type 2 diabetes.
Studies in San Antonio are particularly focused on reducing the long-term complications of diabetes, such as cardiovascular disease and kidney failure, providing new hope for patients with these chronic conditions.
Cardiovascular research in San Antonio is robust, with trials addressing heart disease, hypertension, and stroke - conditions that disproportionately affect local populations. Researchers at UT Health San Antonio and other centers place efforts on new medications, surgical interventions, and non-invasive treatments to improve heart health.
Clinical trials also explore innovative ways to prevent cardiovascular disease, including lifestyle interventions, gene therapies, and cutting-edge medical devices that aim to reduce mortality and improve quality of life.
San Antonio is making important strides in neuroscience and neurological disorders, particularly in the field of Alzheimer’s disease and other neurodegenerative conditions. As the population ages, the need for effective treatments for dementia has grown, and the city’s research centers are involved in trials exploring drugs that slow cognitive decline and preventative therapies for high-risk populations.
Researchers also focus on improving care for patients with Alzheimer’s through non-pharmacological interventions like cognitive behavioral therapy (CBT) and family-centered care models.
Designed to protect participants and ensure ethical research practices, clinical trials in San Antonio follow both federal and state regulations. All clinical trials must comply with FDA guidelines and Good Clinical Practice (GCP) standards, which oversee trial design, participant safety, and data integrity. Additionally, all studies are reviewed and approved by an Institutional Review Board (IRB), which ensures informed consent is obtained, risks are minimized, and the rights of participants are protected.
In Texas, including San Antonio, the Texas Department of State Health Services (DSHS) oversees clinical research to ensure compliance with state-specific laws, particularly in protecting vulnerable populations such as children and military personnel. Researchers must also follow HIPAA guidelines to safeguard participant health information. San Antonio’s research institutions often have additional internal policies and ethics committees that further ensure high standards of safety and compliance throughout the clinical trial process.
Volunteering in a clinical trial provides an opportunity to access cutting-edge treatments and therapies before they are widely available. Participants benefit from specialized care, receiving close attention and monitoring from expert healthcare providers who ensure their well-being throughout the study.
Clinical trial participation is crucial for driving medical advancements and can lead to major breakthroughs in disease treatment and prevention. By taking part, individuals not only access potentially life-changing therapies early but also play a key role in advancing scientific knowledge. This contribution helps shape future healthcare approaches and improves treatment options for countless others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: